Related Experiment Video
Updated: Nov 23, 2025

05:06
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
2.1K
Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study
Wanxia Hu1, Wenhua Xu2, Lei Si3
1School of Health Management, Anhui Medical University, Hefei, China.
Plos One
|December 31, 2020
Summary
The Da Qing Diabetes Prevention program demonstrated long-term cost-effectiveness. This lifestyle intervention is cost-saving and improves health outcomes for individuals with impaired glucose tolerance.
Area of Science:
- Public Health
- Health Economics
- Preventive Medicine
Background:
- Type 2 diabetes prevention is a global health priority.
- Lifestyle interventions show promise in managing impaired glucose tolerance.
- The Da Qing Diabetes Prevention program (DQDP) was a key randomized trial initiated in 1986.
Purpose of the Study:
- To estimate the long-term cost-effectiveness of the DQDP lifestyle intervention.
- To assess the economic value of diabetes prevention strategies in a Chinese population.
- To evaluate health utilities and healthcare costs associated with the DQDP.
Main Methods:
- A Markov Monte Carlo model was employed from a healthcare system perspective.
- Analysis considered 30-year and lifetime time horizons.
- Quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio (ICER) were key outcome measures.
Main Results:
- The intervention was cost-saving over both 30-year and lifetime periods.
- Participants gained an average of 0.74 QALYs (30-year) and 1.44 QALYs (lifetime).
- Cardiovascular disease event hazard ratio significantly influenced the ICER.
Conclusions:
- The DQDP lifestyle intervention offers substantial economic value for Chinese populations with impaired glucose tolerance.
- The program is a cost-saving strategy for diabetes prevention.
- Long-term economic benefits support the implementation of such lifestyle interventions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
721
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
721
Diabetes Mellitus: Type 2 and Gestational
3.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K

